Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo

Blood

Volumn 107, Issue 2, 2006, Pages 637-641

  Aslam, Rukhsana ^b   Speck, Edwin R ^b   Kim, Michael ^b   Crow, Andrew R ^b   Bang, K W Annie ^b   Nestel, Frederick P ^b   Ni, Heyu ^b   Lazarus, Alan H ^b   Freedman, John ^b   Semple, John W ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; THROMBIN; THROMBOCYTE ANTIBODY; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; WESTERN BLOTTING;

EID: 30444436765     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-06-2202     Document Type: Article

References (35)

1. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394-397.
2. Chaudhary PM, Ferguson C, Nguyen V, et al. Cloning and characterization of two Toll/interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. Blood. 1998;91:4020-4027.
3. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A. 1998;95:588-593.
4. Kurt-Jones EA, Mandell L, Whitney C, et al. Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood. 2002;100:1860-1868.
5. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune responses to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;410:1099-1103.
6. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci U S A. 2000;97:13766-13771.
7. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis E, Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303:1529-1531.
8. Lund JM, Alexopoulou L, Sato A, et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A. 2004;101:5598-5603.
9. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-376.
10. Adachi O, Kawai T, Takeda K, et al. Targeted disruption of the MyD88 gene results in loss of IL-1 and IL-18 mediated function. Immunity. 1998;9:143-150.
11. Shiraki R, Inoue N, Kawasaki S, et al. Expression of Toll-like receptors on human platelets. Thromb Res. 2004;113:379-385.
12. Semple J, Aslam R, Freedman J. Murine platelets express Toll like receptor 2: a potential regulator of innate and adaptive immunity [abstract]. Platelets. 2004;15:267.
13. Andonegui G, Kerfoot SM, McNagny K, Ebbert KVJ, Patel KD, Kubes P. Platelets express functional Toll-like receptor-4 (TLR4). Blood. 2005;106:2417-2423.
14. Bennett DE, Tian J, Robert JJ, et al. Platelet-mediated modulation of adaptive immunity: a communication link between innate and adaptive immune compartments. Immunity. 2003;19:9-19.
15. Warkentin TE, Aird WC, Rand JH. Plateletendothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology. 2003;8:497-519.
16. Semple JW, Kim M, Lazarus AH, Freedman J. γ-Globulins prepared from sera of multiparous women bind anti-HLA antibodies and inhibit an established in vivo human alloimmune response. Blood. 2002;100:1055-1059.
17. Semple JW, Speck ER, Cosgrave D, Lazarus AH, Blanchette VS, Freedman J. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity. Blood. 1999;93:713-720.
18. Crow AR, Song S, Semple JW, Freedman J, Lazarus AH. IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of antiidiotype reactivity. Br J Haematol. 2001;115:679-686.
19. Modlin RL, Brightbill HD, Godowski PJ. The toll of innate immunity on microbial pathogens. N Engl J Med. 1999;340:1834-1835.
20. Danese S, de la Motte C, Reyes BM, Sans M, Levine AD, Fiocchi C. T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol. 2004;172:2011-2015.
21. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782-787.
22. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675-680.
23. Coppinger JA, Cagney G, Toomey S, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 2004;103:2096-2104.
24. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391:591-594.
25. Elzey BD, Tian J, Jensen RJ, et al. Platelet-mediated modulation of adaptive immunity: a communication link between innate and adaptive immune compartments. Immunity. 2003;19:9-19.
26. Manthey CLS, Vogel SN. The role of cytokines in host response to endotoxin. Rev Med Microbiol. 1992;3:72-79.
27. Morrison DC, Danner RL, Dinarello CA, et al. Bacterial endotoxins and pathogenesis of Gramnegative infections: current status and future direction. J Endotoxin Res. 1994;1:71-83.
28. Kopydlowski KM, Salkowski CA, Cody MJ, et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol. 1999;163:1537-1544.
29. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice. Science. 1998;282:2085-2088.
30. Hoshino K, Takeuchi O, Kawai T, et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J Immunol. 1999;162:3749-3752.
31. Montrucchio G, Bosco O, Del Sorbo L, et al. Mechanisms of the priming effect of low doses of lipopolysaccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb Haemost. 2003;90:872-881.
32. Kawabata Y, Yang TS, Yokochi TT, et al. Complement system is involved in anaphylactoid reaction induced by lipopolysaccharides in muramyldipeptide treated mice. Shock. 2000;14:572-577.
33. Ohba M, Shibazaki M, Sasano T, Inoue M, Takada H, Endo Y. Platelet responses and anaphylaxis-like shock induced in mice by intravenous injection of whole cells of oral streptococci. Oral Micro Immunol. 2004;19:26-30.
34. Sheu JR, Hung WC, Kan YC, Lee YM, Yen MH. Mechanism involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets. Br J Haematol. 1998;103:29-38.
35. Rietschel ET, Kirikae T, Schade FU, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994;8:217-225.